INmune Bio Inc (INMB)
8.88
+0.19
(+2.19%)
USD |
NASDAQ |
Jun 28, 16:00
8.87
-0.01
(-0.11%)
After-Hours: 20:00
INmune Bio Cash and Short Term Investments (Quarterly): 26.00M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 26.00M |
| December 31, 2023 | 35.85M |
| September 30, 2023 | 41.81M |
| June 30, 2023 | 47.82M |
| March 31, 2023 | 51.00M |
| December 31, 2022 | 52.15M |
| September 30, 2022 | 57.40M |
| June 30, 2022 | 61.21M |
| March 31, 2022 | 66.73M |
| December 31, 2021 | 74.81M |
| September 30, 2021 | 84.47M |
| June 30, 2021 | 39.52M |
| Date | Value |
|---|---|
| March 31, 2021 | 45.34M |
| December 31, 2020 | 21.97M |
| September 30, 2020 | 24.31M |
| June 30, 2020 | 4.817M |
| March 31, 2020 | 5.930M |
| December 31, 2019 | 6.996M |
| September 30, 2019 | 7.383M |
| June 30, 2019 | 9.364M |
| March 31, 2019 | 6.049M |
| December 31, 2018 | 0.1862M |
| September 30, 2018 | 0.6509M |
| December 31, 2017 | 1.371M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
4.817M
Minimum
Jun 2020
84.47M
Maximum
Sep 2021
39.76M
Average
41.81M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| AVITA Medical Inc | 68.18M |
| Xeris Biopharma Holdings Inc | 87.35M |
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |
| iBio Inc | 5.302M |